Mangrove Partners’s Healthcare Capital Corp. Class A common stock HCCC Stock Holding History

Mangrove Partners’s Portfolio HCCC Stock Details HCCC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-606,600	Closed	-$5.96M	–	676
2021 Q4	$5.96M	Buy	606,600 +106,600	+21%	+$1.06M	0.35%	55
2021 Q3	$4.93M	Buy	500,000 +200,000	+67%	+$1.96M	0.44%	57
2021 Q2	$2.9M	Hold	300,000	–	–	0.3%	105
2021 Q1	$2.9M	Buy	+300,000	New	+$2.92M	0.29%	104

Mangrove Partners's HCCC Position: Q1 2022 in Review

Mangrove Partners sold out of Healthcare Capital Corp. Class A common stock (HCCC) in Q1 2022, closing a stake of 606,600 shares — an estimated $5.96M sold.

Mangrove Partners first reported a position in HCCC in Q1 2021 and held it in 4 quarters. The position peaked at $5.96M in Q4 2021. 0 funds tracked by Wall St. Rank hold HCCC as of Q1 2022.

Mangrove Partners reported no remaining Healthcare Capital Corp. Class A common stock position as of Q1 2022 after selling out during the quarter.
Mangrove Partners sold 606,600 Healthcare Capital Corp. Class A common stock shares in Q1 2022, an estimated $5.96M.
Mangrove Partners first reported a position in Healthcare Capital Corp. Class A common stock in Q1 2021 and held it in 4 quarters.
Mangrove Partners's Healthcare Capital Corp. Class A common stock position peaked at $5.96M in Q4 2021.
0 funds tracked by Wall St. Rank held Healthcare Capital Corp. Class A common stock as of Q1 2022.

Based on Mangrove Partners's 13F filing for Q1 2022, filed 16 May 2022.